Report: Cost of dementia to exceed $604 billion, number of cases to double every 20 years
Report: Global cost of dementia is soaring HEALTHBEAT: Somewhat ignored Alzheimer’s tangles get new attention, offer clue to worsening
Alzheimer’s brain tangles offer clue to worsening Number of Japanese at least 100 years old rises even as worries persist about care of elders
Number of centenarians in aging Japan grows again Study: Drugs to strengthen bones may slightly raise the chances of throat cancer
Summary Box: Eli Lilly halts development of potential Alzheimer’s drug in late-stage testing
Aging inmates prompt creation of assisted living center at Washington prison
Aging pitcher, World Series champion Orlando ‘El Duque’ Hernandez aims for one more chance
Aging ‘El Duque’ aims for one more shot in majors Advances in finding Alzheimer’s disease show the need for drugs to stop or slow its course
Psychiatrist Robert Butler, geriatrics expert who coined term ‘ageism,’ dies at 83 more images US government task force urges more postmenopausal women to be screened for osteoporosis more images Drugmaker Merck says it will fight $8 million compensatory damages verdict in Fosamax trialmore images London’s Hyde Park opens capital’s first exercise playground for older people
London opens first exercise playground for elderly Merck: Jury rules against plaintiff claiming osteoporosis pill Fosamax caused dental damage
HEALTHBEAT: Study will put to test growing evidence linking high blood pressure to dementia
Older motorcyclists staying in the saddle longer with comfy, easy to balance 3-wheelers more images Amgen shares fall as company discloses additional FDA Prolia request, Arenesp dataAmgen shares fall after new Prolia request NEW YORK — Amgen Inc. shares fell Thursday over the likelihood that the biotechnology company’s next potential blockbuster will take longer than expected to reach its full sales potential in the market. Amgen’s 3rd-quarter profit rises 24 percent on lower costs as anemia drug sales continue dropAmgen 3Q profit jumps 24 percent on lower costs NEW YORK — Biotechnology company Amgen Inc. said Wednesday lower costs in its research and sales units boosted third-quarter profit by 24 percent, despite a continued downturn in anemia drug sales. UBS analyst boosts price target for Amgen stock, citing osteoporosis drug, stable businessUBS analyst boosts Amgen price target NEW YORK — A UBS analyst on Monday boosted his price target on Amgen Inc., saying the launch of the company’s osteoporosis drug denosumab should drive the stock’s value. 3 Americans win Nobel medicine prize for finding mechanism that protects chromosomes3 Americans share Nobel medicine prize NEW YORK — Three Americans won the Nobel prize in medicine on Monday for discovering how chromosomes protect themselves as cells divide, work that has inspired experimental cancer therapies and may offer insights into aging. Happy 100th birthday! Most babies born since 2000 will hit 100, life expectancy still risingMost babies born this century will live to 100 years
Inverness Medical plans $100 M senior note offering to fund acquisitionInverness Medical to offer $100 M in senior notes WALTHAM, Mass. — Diagnostic test maker Inverness Medical Innovations Inc. said Tuesday it plans to offer $100 million in senior notes due in 2016 to help fund its acquisition of Free & Clear Inc. Report finds Alzheimer’s, dementia afflict more than 35 million worldwide and rising rapidlyReport: 35 million-plus worldwide have dementia WASHINGTON — More than 35 million people around the world are living with Alzheimer’s disease or other types of dementia, says the most in-depth attempt yet to assess the brain-destroying illness — and it’s an ominous forecast as the population grays. |
|
LONDON — Most babies born in rich countries this century will eventually make it to their 100th birthday, new research says. Danish experts say that since the 20th century, people in developed countries are living about three decades longer than in the past. Surprisingly, the trend shows little sign of slowing down.